Cargando…

Susceptibility to false discovery in biomarker research using liquid chromatography–high resolution mass spectrometry based untargeted metabolomics profiling

Detalles Bibliográficos
Autores principales: Zhang, Pengwei, Ang, Irene L., Lam, Melody M.T., Wei, Rui, Lei, Kate M.K., Zhou, Xingwang, Lam, Henry H.N., He, Qing‐Yu, Poon, Terence C.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236120/
https://www.ncbi.nlm.nih.gov/pubmed/34185426
http://dx.doi.org/10.1002/ctm2.469
_version_ 1783714472467103744
author Zhang, Pengwei
Ang, Irene L.
Lam, Melody M.T.
Wei, Rui
Lei, Kate M.K.
Zhou, Xingwang
Lam, Henry H.N.
He, Qing‐Yu
Poon, Terence C.W.
author_facet Zhang, Pengwei
Ang, Irene L.
Lam, Melody M.T.
Wei, Rui
Lei, Kate M.K.
Zhou, Xingwang
Lam, Henry H.N.
He, Qing‐Yu
Poon, Terence C.W.
author_sort Zhang, Pengwei
collection PubMed
description
format Online
Article
Text
id pubmed-8236120
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82361202021-06-29 Susceptibility to false discovery in biomarker research using liquid chromatography–high resolution mass spectrometry based untargeted metabolomics profiling Zhang, Pengwei Ang, Irene L. Lam, Melody M.T. Wei, Rui Lei, Kate M.K. Zhou, Xingwang Lam, Henry H.N. He, Qing‐Yu Poon, Terence C.W. Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-06-27 /pmc/articles/PMC8236120/ /pubmed/34185426 http://dx.doi.org/10.1002/ctm2.469 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Zhang, Pengwei
Ang, Irene L.
Lam, Melody M.T.
Wei, Rui
Lei, Kate M.K.
Zhou, Xingwang
Lam, Henry H.N.
He, Qing‐Yu
Poon, Terence C.W.
Susceptibility to false discovery in biomarker research using liquid chromatography–high resolution mass spectrometry based untargeted metabolomics profiling
title Susceptibility to false discovery in biomarker research using liquid chromatography–high resolution mass spectrometry based untargeted metabolomics profiling
title_full Susceptibility to false discovery in biomarker research using liquid chromatography–high resolution mass spectrometry based untargeted metabolomics profiling
title_fullStr Susceptibility to false discovery in biomarker research using liquid chromatography–high resolution mass spectrometry based untargeted metabolomics profiling
title_full_unstemmed Susceptibility to false discovery in biomarker research using liquid chromatography–high resolution mass spectrometry based untargeted metabolomics profiling
title_short Susceptibility to false discovery in biomarker research using liquid chromatography–high resolution mass spectrometry based untargeted metabolomics profiling
title_sort susceptibility to false discovery in biomarker research using liquid chromatography–high resolution mass spectrometry based untargeted metabolomics profiling
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236120/
https://www.ncbi.nlm.nih.gov/pubmed/34185426
http://dx.doi.org/10.1002/ctm2.469
work_keys_str_mv AT zhangpengwei susceptibilitytofalsediscoveryinbiomarkerresearchusingliquidchromatographyhighresolutionmassspectrometrybaseduntargetedmetabolomicsprofiling
AT angirenel susceptibilitytofalsediscoveryinbiomarkerresearchusingliquidchromatographyhighresolutionmassspectrometrybaseduntargetedmetabolomicsprofiling
AT lammelodymt susceptibilitytofalsediscoveryinbiomarkerresearchusingliquidchromatographyhighresolutionmassspectrometrybaseduntargetedmetabolomicsprofiling
AT weirui susceptibilitytofalsediscoveryinbiomarkerresearchusingliquidchromatographyhighresolutionmassspectrometrybaseduntargetedmetabolomicsprofiling
AT leikatemk susceptibilitytofalsediscoveryinbiomarkerresearchusingliquidchromatographyhighresolutionmassspectrometrybaseduntargetedmetabolomicsprofiling
AT zhouxingwang susceptibilitytofalsediscoveryinbiomarkerresearchusingliquidchromatographyhighresolutionmassspectrometrybaseduntargetedmetabolomicsprofiling
AT lamhenryhn susceptibilitytofalsediscoveryinbiomarkerresearchusingliquidchromatographyhighresolutionmassspectrometrybaseduntargetedmetabolomicsprofiling
AT heqingyu susceptibilitytofalsediscoveryinbiomarkerresearchusingliquidchromatographyhighresolutionmassspectrometrybaseduntargetedmetabolomicsprofiling
AT poonterencecw susceptibilitytofalsediscoveryinbiomarkerresearchusingliquidchromatographyhighresolutionmassspectrometrybaseduntargetedmetabolomicsprofiling